BILLING CODE 6560-50-P
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2024-0057; FRL-11683-06-OCSPP]
Certain New Chemicals; Receipt and Status Information for June 2024
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
SUMMARY: EPA is required under the Toxic Substances Control Act (TSCA), as amended by
the Frank R. Lautenberg Chemical Safety for the 21st Century Act, to make information publicly
available and to publish information in the Federal Register pertaining to submissions under
TSCA Section 5, including notice of receipt of a Premanufacture notice (PMN), Significant New
Use Notice (SNUN) or Microbial Commercial Activity Notice (MCAN), including an amended
notice or test information; an exemption application (Biotech exemption); an application for a
test marketing exemption (TME), both pending and/or concluded; a notice of commencement
(NOC) of manufacture (including import) for new chemical substances; and a periodic status
report on new chemical substances that are currently under EPA review or have recently
concluded review. This document covers the period from 6/01/2024 to 6/30/2024.
DATES: Comments identified by the specific case number provided in this document must be
received on or before [INSERT DATE 30 DAYS AFTER DATE OF PUBLICATION IN THE
FEDERAL REGISTER].
ADDRESSES: Submit your comments, identified by docket identification (ID) number EPAHQ-OPPT-2024-0057, through the Federal eRulemaking Portal at https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit electronically any
information you consider to be Confidential Business Information (CBI) or other information
whose disclosure is restricted by statute. Additional instructions on commenting and visiting the
docket, along with more information about dockets generally, is available at
https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: For technical information contact: Jim
Rahai, Project Management and Operations Division (MC 7407M), Office of Pollution
Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001; telephone number: (202) 564-8593; email address:
rahai.jim@epa.gov.
For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave.,
Rochester, NY 14620; telephone number: (202) 554-1404; email address: TSCAHotline@epa.gov.
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. What action is the Agency taking?
This document provides the receipt and status reports for the period from 6/01/2024 to
6/30/2024. The Agency is providing notice of receipt of PMNs, SNUNs, and MCANs (including
amended notices and test information); an exemption application under 40 CFR part 725
(Biotech exemption); TMEs, both pending and/or concluded; NOCs to manufacture a new
chemical substance; and a periodic status report on new chemical substances that are currently
under EPA review or have recently concluded review.
EPA is also providing information on its web site about cases reviewed under the
amended TSCA, including the section 5 PMN/SNUN/MCAN and exemption notices received,
the date of receipt, the final EPA determination on the notice, and the effective date of EPA’s
determination for PMN/SNUN/MCAN notices on its web site at:
https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/statuspre-manufacture-notices. This information is updated on a weekly basis.
B. What is the Agency's authority for taking this action?
Under the Toxic Substances Control Act (TSCA), 15 U.S.C. 2601 et seq., a chemical
substance may be either an “existing” chemical substance or a “new” chemical substance. Any

chemical substance that is not on EPA’s TSCA Inventory of Chemical Substances (TSCA
Inventory) is classified as a “new chemical substance,” while a chemical substance that is listed
on the TSCA Inventory is classified as an “existing chemical substance.” (See TSCA section
3(11).) For more information about the TSCA Inventory please go to: https://www.epa.gov/tscainventory.
Any person who intends to manufacture (including import) a new chemical substance for
a non-exempt commercial purpose, or to manufacture or process a chemical substance in a nonexempt manner for a use that EPA has determined is a significant new use, is required by TSCA
section 5 to provide EPA with a PMN, MCAN, or SNUN, as appropriate, before initiating the
activity. EPA will review the notice, make a risk determination on the chemical substance or
significant new use, and take appropriate action as described in TSCA section 5(a)(3).
TSCA section 5(h)(1) authorizes EPA to allow persons, upon application and under
appropriate restrictions, to manufacture or process a new chemical substance, or a chemical
substance subject to a significant new use rule (SNUR) issued under TSCA section 5(a)(2), for
“test marketing” purposes, upon a showing that the manufacture, processing, distribution in
commerce, use, and disposal of the chemical will not present an unreasonable risk of injury to
health or the environment. This is referred to as a test marketing exemption, or TME. For more
information about the requirements applicable to a new chemical go to: https://www.epa.gov/
chemicals-under-tsca.
Under TSCA sections 5 and 8 and EPA regulations, EPA is required to publish in the
Federal Register certain information, including notice of receipt of a PMN/SNUN/MCAN
(including amended notices and test information); an exemption application under 40 CFR part
725 (biotech exemption); an application for a TME, both pending and concluded; NOCs to
manufacture a new chemical substance; and a periodic status report on the new chemical
substances that are currently under EPA review or have recently concluded review.
C. Does this action apply to me?

This action provides information that is directed to the public in general.
D. Does this action have any incremental economic impacts or paperwork burdens?
No.
E. What should I consider as I prepare my comments for EPA?
1. Submitting confidential business information (CBI). Do not submit this information to
EPA through regulations.gov or email. Clearly mark the part or all of the information that you
claim to be CBI. For CBI information in a disk or CD-ROM that you mail to EPA, mark the
outside of the disk or CD-ROM as CBI and then identify electronically within the disk or CDROM the specific information that is claimed as CBI. In addition to one complete version of the
comment that includes information claimed as CBI, a copy of the comment that does not contain
the information claimed as CBI must be submitted for inclusion in the public docket. Information
so marked will not be disclosed except in accordance with procedures set forth in 40 CFR Part 2.
2. Tips for preparing your comments. When preparing and submitting your comments,
see the commenting tips at https://www.epa.gov/dockets/commenting-epa-dockets.
II. Status Reports
In the past, EPA has published individual notices reflecting the status of TSCA section 5
filings received, pending or concluded. In 1995, the Agency modified its approach and
streamlined the information published in the Federal Register after providing notice of such
changes to the public and an opportunity to comment (see the Federal Register of May 12, 1995
(60 FR 25798) (FRL-4942-7)). Since the passage of the Lautenberg amendments to TSCA in
2016, public interest in information on the status of section 5 cases under EPA review and, in
particular, the final determination of such cases, has increased. In an effort to be responsive to
the regulated community, the users of this information, and the general public, to comply with
the requirements of TSCA, to conserve EPA resources and to streamline the process and make it
more timely, EPA is providing information on its web site about cases reviewed under the
amended TSCA, including the section 5 PMN/SNUN/MCAN and exemption notices received,

the date of receipt, the final EPA determination on the notice, and the effective date of EPA’s
determination for PMN/SNUN/MCAN notices on its web site at:
https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/statuspre-manufacture-notices. This information is updated on a weekly basis.
III. Receipt Reports
For the PMN/SNUN/MCANs that have passed an initial screening by EPA during this
period, table I provides the following information (to the extent that such information is not
subject to a CBI claim) on the notices screened by EPA during this period: The EPA case
number assigned to the notice that indicates whether the submission is an initial submission, or
an amendment, a notation of which version was received, the date the notice was received by
EPA, the submitting manufacturer (i.e., domestic producer or importer), the potential uses
identified by the manufacturer in the notice, and the chemical substance identity.
As used in each of the tables in this unit, (S) indicates that the information in the table is
the specific information provided by the submitter, and (G) indicates that this information in the
table is generic information because the specific information provided by the submitter was
claimed as CBI. Submissions which are initial submissions will not have a letter following the
case number. Submissions which are amendments to previous submissions will have a case
number followed by the letter “A” (e.g. P-18-1234A). The version column designates
submissions in sequence as “1”, “2”, “3”, etc. Note that in some cases, an initial submission is
not numbered as version 1; this is because earlier version(s) were rejected as incomplete or
invalid submissions. Note also that future versions of the following tables may adjust slightly as
the Agency works to automate population of the data in the tables.
Table I. – PMN/SNUN/MCANs Approved* from 6/01/2024 to 6/30/2024.
Case
No.

Version

Received
Date

Manufacturer Use

Chemical Substance

P-220126A

06/07/2024

Takasago

(S) This polymer
constitutes the
wall of
microcapsules
containing
fragrance that can
be used in
different
homecare and
personal-care
applications

(S) Cellulose, polymer
with 1,1'-[2-ethyl-2-[(3mercapto-1oxopropoxy)methyl]-1,3propanediyl] bis(3mercaptopropanoate) and
1,2,3-propanetriol bis(2methyl-2-propenoate),
peroxydisulfuric acid
([(HO)S(O)2]2O2)
ammonium salt (1:2)- and
sodium (disulfite) (2:1)initiated

P-220149A

06/14/2024

Colonial
Chemical, Inc.

(S) Hexanoic acid, 3,5,5trimethyl-, sodium salt
(1:1)

P-230150A

06/19/2024

CBI

(S) All-purpose
hard surface
cleaner, Low
foam floor
scrubber, Spray
Metal Cleaning
Concentrate
(G) Industrial use
for roll-on,
brushing, and
spray application

P-240013A

06/13/2024

Momentive
Performance
Materials

(S) Resin/binder
in paint
formulations for
industrial
coatings

P-240040A

06/20/2024

Sudoc, LLC

P-240083A
P-240085A

06/21/2024

CBI

06/04/2024

Luna Labs

(G) Additive for
commercial, nonspray commercial
and consumer
applications
(G) Ingredient for
cleaning products
(S) Curative for
polyurethane
sealant

(G) Branched Glycidyl
Ester and Bisphenol
Glycidyl Ether polymer
adduct with Aralkyl
Diamine
(G) Siloxanes and
Silicones, di-Me,
hydroxy-terminated,
polymers with 3-[[3alkoxy-1(alkoxycarbonyl)-3oxoalkyl]heteroatom]
propyl Me
silsesquioxanes, alkoxyterminated
(G) Metal,
aqua[(alkylnitrocarbocycl
epolyheteropolyheterocycl
opolyalkane-ketone)polyoxidato]-, metal
(G) Branched alcohol
alkoxylate
(S) Siloxanes and
Silicones, di-Me, 3-[[[[4[(4isocyanantocyclohexyl)me
thyl] cyclohexyl] amino]
carbonyl] oxy] propyl
group terminated

P-240110A

05/31/2024

US Paint Corp. (G) Component
of coating

P-240114A

05/31/2024

HPC Holdings, (G) Chemical
Inc.
Intermediate

P-240125
P-240128A

04/17/2024

CBI

06/06/2024

CBI

P-240132A
P-240137

06/11/2024

CBI

04/19/2024

P-240160A

06/05/2024

CBI

(G) Photoacid
generator use at
customer sites

P-240163A

06/13/2024

CBI

P-240164

06/13/2024

P-240166

06/24/2024

Huntsman
International,
LLC
Nagase
America, LLC

(G) Gas
adsorption
cartridges.
Protective
Garments
(S) Intermediate
in the production
of a catalyst
(S) Heat transfer
fluid in a cooling
system for a
reaction chamber

(G) Plasticizer
Additive
(S) Chemical
intermediate
(G) Sizing agent

KAO
(G) Component
Specialties
of liquid
Americas, LLC detergent

(G) Alkyl fatty acids,
polymers with substituted
alkene, heteromonocyclic
alkenoate, substituted
heteropolycyclic,
substituted alkyl
alkenoate, substituted
alkanoic acid,
carbomonocyclic
dicarboxylic acid, alkyl
alkenoate, alkyl alkenoate,
alkenoic acid, substituted
carbomonocycle, and
trisubstituted alkyl, alkyl
substituted alkyl alkanoate
and substituted bis
alkylalkanenitrile-initiated
(S) 1,3-Butanediol, 4,4,4trifluoro-3(trifluoromethyl)(G) Dialkyl
carbomonocyclodiate
(G)
Tetramethyldisiloxanediyl
bis[propylcarbonyl]
(S) Sunflower oil, oleic
acid-high, maleated
(G) Alkene, reaction
products with oxide,
hydrolyzed, alkali metal
salts
(G) Iodonium, bis(dialkyl
carbomonocycle) salt with
alkyl carbomonocycle
hetero-acid
(G) Transition metal
polykis (heteroatom
substituted
carbomonocycle),
hydroxy- oxo(S) 2-Propanamine, N ,N
'-(oxydi-2,1ethanediyl)bis(S) Pentane,
1,1,2,2,3,3,4,4-octafluoro5-(1,1,2,2tetrafluoroethoxy)-

In table II of this unit, EPA provides the following information (to the extent that such
information is not claimed as CBI) on the NOCs that have passed an initial screening by EPA

during this period: The EPA case number assigned to the NOC including whether the submission
was an initial or amended submission, the date the NOC was received by EPA, the date of
commencement provided by the submitter in the NOC, a notation of the type of amendment
(e.g., amendment to generic name, specific name, technical contact information, etc.) and
chemical substance identity.
Table II—NOCs Approved* From 6/01/2024 to 6/30/2024.
Case
No.

Received
Date

Commencement
Date

J-240009
J-240010
J-240011
J-240012
J-240013
P-150446
P-170235
A
P-180226
P-190166
A
P-220025

06/03/2024

05/30/2024

If amendment,
type of
amendment
N

06/03/2024

05/30/2024

N

06/03/2024

05/30/2024

N

06/03/2024

05/30/2024

N

06/03/2024

05/30/2024

N

06/10/2024

06/05/2024

N

05/31/2024

11/28/2022

05/31/2024

03/04/2024

Amended the
generic
chemical name
N

06/14/2024

06/27/2022

06/19/2024

06/10/2024

Amended the
generic
chemical name
N

P-220090
P-220093

06/14/2024

05/21/2024

N

06/03/2024

05/24/2024

N

Chemical Substance
(G) Chromosomally-modified
saccharomyces cerevisiae
(G) Chromosomally modified
saccharomyces cerevisiae
(G) Chromosomally modified
saccharomyces cerevisiae
(G) Chromosomally-modified
saccharomyces cerevisiae
(G) Chromosomally-modified
saccharomyces cerevisiae
(G) Rare earth doped zirconium
oxide
(G) Fatty amidopropyl trialkyl
ammonium alkyl sulfate
(G) Trialkylammonioethyl fattyalkylate, alkyl sulfate
(G) Triaryl sulfonium,
multicycloalkylalkoxycarbonyloxym
onofluoroalkylsulfonate
(G) Oxirane, 2-(chloromethyl)-,
homopolymer, ether with dialkylalkanediol (2:1)
(S) 4,8,11-dodecatrienal
(G) Alkenoic acid, alkyl-substituted
alkyl ester, polymer with
(polyalkylamino)alkyl
alkylalkenoate, alkyl-substituted
alkylalkenoate, alpha-(alkyloxoalkenyl)-omega-alkoxypoly(oxy1,2-ethanediyl), [(alkoxy-alkylalkenyl)oxy]polyalkylsilaneinitiated, compds. with polyethylene
glycol phosphoric acid based alkyl
ether

P-220175
P-871177

06/06/2024

05/23/2024

N

06/20/2024

03/21/1990

N

(G) Modified silsesquioxane,
alkoxy-terminated
(G) Siloxanes and silicones, di-me,
vinyl group-terminated, reaction
products with
trisiladioxadimethoxyalkanes

In table III of this unit, EPA provides the following information (to the extent such
information is not subject to a CBI claim) on the test information that has been received during
this time period: The EPA case number assigned to the test information; the date the test
information was received by EPA, the type of test information submitted, and chemical
substance identity.
Table III—Test Information Received From 6/01/2024 to 6/30/2024.
Case No.
L-24-0235

Received
Date
06/20/2024

Type of Test Information
Bioconcentration Factor Predictions; Bacterial
Reverse Mutation Test (OECD Test Guideline
471); Prenatal Developmental Toxicity Study
(OECD Test Guideline 414); Carcinogenicity
(OECD Test Guideline 451); Acute Dermal
Toxicity (OECD Test Guideline 402); Skin
Sensitization (OECD Test Guideline 406);
Acute Dermal Irritation (OECD Test Guideline
404); Acute Eye Irritation (OECD Test
Guideline 405); Chromosomal Aberration
Testing

Chemical
Substance
(G) Diisopropyl
imidazolium salt

P-12-0241

06/21/2024

Analyte Reports

P-14-0712

06/27/2024

Polychlorinated Dibenzodioxins and
Polychlorinated dibenzofurans Testing

P-16-0543

06/25/2024

Exposure Monitoring Report

P-21-0166

06/20/2024

Gel Permeation Chromatography Testing

(G) [2-Propenoic
acid, 2-methyl-, 2hydroxyethyl
esters, telomers
with c18-26-alkyl
acrylate, 1dodecanethiol, N(hydroxymethyl)-2methyl-2propenamide,
3,3,4,4,5,5,6,6,7,7,8
,8,8tridecaflourooctyl
methacrylate, 2,2[1,2
diazenedylbis(1methylethylidene)]
bis[4,5-dihydro1Himidazole]hydro
chloride (1:2)initiated]
(S) Waste plastics,
pyrolyzed, C5-55
fraction
(G)
Halogenophosphori
c acid metal salt
(G) Siloxanes and
silicones, di-me,
[alkylpiperaziniumhydroxyalkoxy]alk
yl groupterminated,
arylsulfonates
(salts)

P-210180, P22-0086,
P-220122, P22-0179,
P-220180, P24-0097

6/20/2024

Determination of Dissociation Constant
(Conductometric Method)

(G) Sulfonium,
(halocarbomonocyc
le)diphenyl-, salt
with 1heterosubstituted-2methylalkyl
trihalobenzoate
(1:1); (G)
Phenoxathiinium,
10-phenyl-, 5-alkyl2-alkyl-4-(2,4,6substituted tricarbopolycycle,
heteroacid)benzenesulfon
ate (1:1); (G)
Heterotrisubstituted
-bile acid, 1(difluorosulfomethy
l)-2,2,2trifluoroethyl ester,
ion(1-), (5)-, 5phenyldibenzothiop
henium(1:1); (G)
Sulfonium,
(alkylsubstitutedph
enyl)diphenyl-, salt
with 1(heterosubstitutedal
kyl)-2,2,2triheterosubstituted
alkyl
trisubstitutedbenzoa
te (1:1); (G)
Dibenzothiopheniu
m, 5-phenyl-, 4-[1(heterosubstitutedal
kyl)-2,2,2triheterosubstituted
alkoxy]-4-oxoalkyl
trisubstitutedbenzoa
te (1:1); (G)
Sulfonium, tris(4fluorophenyl)-,
(substitutedphenox
y)alkyl
substitutedbenzoate
(1:1)

P-210202, P23-0104

06/07/2024

Determination of Water Solubility (Shake Flask
Method)

P-22-0056

06/25/2024

Determination of Tin in Dermal Penetration
Media Samples Validation

P-22-0086

06/20/2024

Dissociation Constants in Water (OECD Test
Guideline 112)

P-22-0122

06/20/2024

Dissociation Constants in Water (OECD Test
Guideline 112)

(G) Sulfonium,
carbomonocycle
bis[(trihaloalkyl)car
bomonocycle],
substituted
carbomonocyclic
ester; (G)
Sulfonium,
carbomonocycle
bis[(trihaloalkyl)car
bomonocycle],
disubstituted
carbomonocyclic
ester
(S) Tin,
dioctylbis(2,4pentanedionato.kappa.o2,.kappa.o4
)(G)
Phenoxathiinium,
10-phenyl-, 5-alkyl2-alkyl-4-(2,4,6substituted tricarbopolycycle,
heteroacid)benzenesulfon
ate (1:1)
(G)
Heterotrisubstituted
-bile acid, 1(difluorosulfomethy
l)-2,2,2trifluoroethyl ester,
ion(1-), (5)-, 5phenyldibenzothiop
henium(1:1)

P-24-0137

04/19/2024

Acute Eye Irritation (OECD Test Guideline
405); Combined Repeated Dose Toxicity with
the Reproduction/Development Toxicity
Screening Test (OECD Test Guideline 422);
Earthworm, Acute Toxicity Tests (OECD Test
Guideline 207); Daphnia sp., Acute
Immobilization Test (OECD Test Guideline
202); Daphnia magna Reproduction Test
(OECD Test Guideline 211); Freshwater and
Saltwater Fish Acute Toxicity Test (OECD Test
Guideline 203); In Vitro Mammalian Cell Gene
Mutation Test (OECD Test Guideline 476);
Mammalian Spermatogonial Chromosomal
Aberration Test (OECD Test Guideline 483);
Prenatal Developmental Toxicity Study (OECD
Test Guideline 414); Inherent Biodegradability
– Concawe Test (OCSPP Test Guideline
835.3215); Ready Biodegradability (OECD
Test Guideline 301); Fish Short-Term
Reproduction (OECD Test Guideline 299);
Seed Germination/Root Elongation Toxicity
Test (OPPTS Test Guideline 850.4200);
Sediment-Water Chironomid Toxicity Test
Using Spiked Sediment (OECD Test Guideline
218); Skin Sensitization (OECD Test Guideline
406); 90-Day Oral Toxicity in Rodents (OECD
Test Guideline 408); Modified Activated
Sludge, Respiration Inhibition Test (OCSPP
Test Guideline 850.3300); Acute Dermal
Irritation (OECD Test Guideline 404); Acute
Dermal Toxicity/Pathology (OCSPP Test
Guideline 885.3100); Acute Oral
Toxicity/Pathogenicity (OCSPP Test Guideline
885.3050); Algal Toxicity (OECD Test
Guideline 201); Adsorption/Desorption (Batch
Equilibrium) (OECD Test Guideline 106);
Bacterial Reverse Mutation Test (OECD Test
Guideline 471)

(G) Alkene,
reaction products
with oxide,
hydrolyzed, alkali
metal salts

If you are interested in information that is not included in these tables, you may contact
EPA’s technical information contact or general information contact as described under FOR
FURTHER INFORMATION CONTACT to access additional non-CBI information that may
be available.
Authority: 15 U.S.C. 2601 et seq.
Dated: July 15, 2024.

Pamela Myrick,
Director, Project Management and Operations Division,
Office of Pollution Prevention and Toxics.
[FR Doc. 2024-15856 Filed: 7/17/2024 8:45 am; Publication Date: 7/18/2024]